Grading and Staging NAFLD

For a quick reference of how to grade and stage histopathological lesions of non-alcoholic fatty liver disease....



Grading for Steatosis


GRADE 1. <33% of hepatocytes affected

GRADE 2. 33-66% of hepatocytes affected

GRADE 3. >66% of hepatocytes affected


Grading for Steatohepatitis


GRADE 1. MILD

Steatosis

  • Predominantly MACROvesicular

  • Involves up to 66% of lobules

Ballooning

  • Occasional, hepatocytes around ZONE 3

Lobular Inflammation

  • Scattered and MILD acute inflammation (PMNs)

  • Occasional chronic inflammation (lymphs)

Portal Inflammation

  • None or Mild


GRADE 2. MODERATE

Steatosis

  • Any degree

  • Usually mixed MACRO and MICRO-vesicular steatosis

Ballooning

  • OBVIOUS, present in ZONE 3

Lobular Inflammation

  • PMNs may be noted in association with ballooned hepatocytes

  • PERI-CELLULAR fibrosis

  • Mild chronic inflammation (lymphocytes) may be seen

Portal Inflammation

  • Mild to Moderate


GRADE 3. SEVERE

Steatosis

  • Typically involves >66% of lobules (PAN-ACINAR)

  • Commonly MIXED (Macro & Micro-vesicular)

Ballooning

  • MARKED- Predominantly ZONE 3

Lobular Inflammation

  • Scattered acute (PMN) and chronic (lymph) inflammation

  • PMNs may be concentrated in zone 3 areas of ballooning

  • PERI-SINUSOIDAL fibrosis

Portal Inflammation

  • Mild to Moderate


Staging for Fibrosis


STAGE 1:

Zone 3 perivenular, perisinusoidal, or pericellular fibrosis

Focal or extensive


STAGE 2:

Same as stage 1, with focal or extensive PERIPORTAL (zone 1) fibrosis


STAGE 3:

Same as above, with BRIDGING FIBROSIS (focal or extensive)


STAGE 4:

Cirrhosis (forms nodules)




Pictures will be uploaded soon...


Reference:

David A. Sass et al. "Nonalcoholic Fatty Liver Disease: A clinical Review". Digestive Diseases and Sciences. Vol 50, No. 1 (January 2005), pp 171-180. DOI: 10.1007/s10620-005-1267-z


Zachary D. Goodman. "Grading and staging systems for inflammation and fibrosis in chronic liver diseases". 0168-8278/$32.00 Published by Elsevier B.V. on behalf of the European Association for the Study of the Liver.

doi:10.1016/j.jhep.2007.07.006

60 views
  • Facebook - Black Circle
  • Twitter - Black Circle
  • Pinterest - Black Circle

DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE

These posts contain high yield information collected from various educational resources including textbooks, journal articles, educational websites and more. They are intended for educational use only and should NOT be taken as medical advice. I strongly believe the spreading of knowledge and depth of learned information should be encouraged in today's society rather than coveted. Membership is required to view these posts  and should be used solely for educational purposes only.